Rite Aid

(RAD) - Get Report

said January same-store sales rose 8.3%. Total drugstore sales for the four-week period rose 6.8% to $1.16 billion from $1.08 billion for the same period last year.

Earnings Reports & Outlooks

Myriad Genetics

(MYGN) - Get Report

reported a second-quarter loss of 10 cents a share, beating estimates by 3 cents. Total revenue rose to $13.5 million from $12 million a year ago.

Oxford Health Plans

(OHP)

reported fourth-quarter earnings of $1 a share, including gains totaling 15 cents. Analysts were expecting a profit of 78 cents. Revenue rose to $1.12 billion from $1.04 billion in the year-ago quarter.

United Auto Group

(UAG) - Get Report

reported fourth-quarter earnings of 32 cents a share, topping the consensus estimate by a penny. Revenue increased 30.4% from the same quarter a year earlier to $1.6 billion. The company expects to earn 29 cents in the first quarter and at least $1.73 a share in 2002. Analysts are looking for earnings of 26 cents in the first quarter and $1.67 for the year.

Mergers, Acquisitions & Joint Ventures

GenVec

(GNVC)

signed a contract with a division of the National Institutes of Health in which the company will use its adenovector technology to develop and manufacture AIDS vaccine candidates. The contract has a life of up to three years and a potential value of $10.2 million.

InVision Technologies

(INVN)

received orders totaling around $8.2 million for explosives detection systems from the Transportation Ministry of Canada, Service Technique des Bases Aeriennes of France and El Al Israel Airlines.

A unit of

OSI Systems

(OSIS) - Get Report

received an order from the Federal Aviation Administration for carry-on baggage X-ray screening systems. The order is valued at about $5 million. The company will begin shipping the systems this quarter.

Teva Pharmaceutical Industries

(TEVA) - Get Report

made a firm offer to acquire

Bayer's

French generic business, including marketing and manufacturing activities. Terms of the offer weren't disclosed.

Analyst Actions

CIBC World Markets upgraded

Charles Schwab

(SCH)

to buy from hold and put a price target of $17 on the stock.

Offerings

J.B. Hunt

(JBHT) - Get Report

priced a 2.2 million share spot offering by the company's senior chairman at $25.10 each, according to

Briefing.com

.